experience we're looking for - Demonstrated success as a pharmaceutical sales representative. - Profound knowledge of medical... professionals, illustrating the clinical benefits of our portfolio. - Cultivate robust relationships with medical staff...
bonus level, corporate car, medical insurance (for the employee and children, additional discount given for close relatives... to building an outstanding, inclusive work environment and diverse teams' representative of the patients and communities we serve...
, corporate car, medical insurance (for the employee and children, additional discount given for close relatives), life insurance... teams' representative of the patients and communities we serve. Join our Novartis Network: Not the right Novartis role...
: Minimum 2 year of experience as a Sales Development Representative or Sales Manager B2C. Fluent in English with excellent... communication skills (C1-C2) and Russian! Experience in medical tourism, B2C sales of hair transplant services is desirable...
) for products under development as a representative of the RU&CIS RA in order to determine a strategy for registering products in... activities. Qualifications: University degree in Pharmacy or Life Sciences. Post-graduate study, medical residency...
teams to continuously improve the overall chauffeur experience. Act as a representative and spokesperson for the company... and above. What we Offer Highly competitive compensation package Medical, life and critical illness insurance Lunch allowance Allowance...
(9.00-18.00) Medical insurance after 3 months of probation Meal allowance CV in English HS Ad (LG Group Corporation's in-house... has representative offices in Beijing, New York, Sao Paulo, Tokyo, Los Angeles,Frankfurt, Dubai, New Delhi, Moscow, etc. Totaly - 31...
medical, pharmaceutical, or chemical education. Experience as a medicalrepresentative/advisor is a benefit. Experience in... projects initiated within the technical-regulatory network. Working with medical scientific literature and scientific...
Regulatory affairs specialist In-Vitro Diagnostic Become part of one of the fastest growing Medical Devices companies... affairs professional, with proven in-depth knowledge of IVD medical devices registration. You will be responsible...
Higher marketing spends, sales and distribution expenses, and a slightly higher loss run-rate for the eB2B business weigh on Nykaa's margins Continue Reading »
On November 18, Hazoor Multi Projects' stock reached ₹53.25 after reporting strong Q2 growth. The stock is up 295% in the last year and 33,180% over five years. Continue Reading »
Oman’s state energy company is seeking to raise as much as $490 million from the initial public offering of its methanol and liquefied petroleum gas unit, the latest in a flurry of deals from the region. Continue Reading »
In its earnings review, MOSL noted a 1% YoY decline in performance, impacted by global commodities. Notable companies like Hindalco and Apollo Hospitals showed strong growth. The downgrade ratio is at its weakest since FY21, suggesting a challenging earnings landscape ahead. Continue Reading »
Lamosaic India IPO opens on November 21 and closes on November 26, with a price band of ₹200 per share. The company reported significant growth, with a 75.25% revenue increase and a 102.13% PAT rise for the financial year ending March 2024. Continue Reading »
Analysts favor Hero MotoCorp shares over Bajaj Auto, citing the company's potential to capitalize on a recovery in rural demand. They anticipate robust volume growth in the near term, driven by increased demand for Hero MotoCorp's new product launches. Continue Reading »
PTC Industries' shares rose 4.3% to ₹11,550 after reporting strong Q2 FY25 results, with total income increasing by 34% YoY. PAT grew 112.7% YoY, boosted by new contracts in the aerospace and defence sectors. Investor Mukul Agrawal holds a 1.07% stake, having seen a 375% rise since September 2022. Continue Reading »
Multibagger stock in 2024: Blue Cloud Softech Solutions stock surged 5% today after the Q2FY25 results. The stock has already risen 150% in 2025 so far, giving multibagger returns to investors. Continue Reading »